ArticleCancer research2022

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.

Benedetta Pellegrino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.